A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 17 October 2011 |
| Author/s | |
| Publication date | October 17, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |